Skip to main content
Premium Trial:

Request an Annual Quote

Waters Q4 Organic Sales Increase 7 Percent on Strong Sales in Asia

NEW YORK, Jan. 24 (GenomeWeb News) - Waters today reported that fourth-quarter sales increased 3 percent on strong growth in its chromatography business and sales in Asia.

 

Total sales for the three months ended Dec. 31 increased to $332 million from $324 million one year ago. Eliminating the effects of foreign currency, sales grew by 7 percent, the company said.

 

R&D spending in the period increased slightly to $16.7 million from $16.5 million year over year.

 

Waters' net income increased to $78.2 million, or $0.72 per basic share, from $71.5 million, or $0.59 per basic share in the year-ago period.

 

CEO and President Douglas Berthiaume said the revenue and profit "exceeded our expectations."

 

As of Jan. 1, Waters had approximately $494 million in cash and equivalents on hand.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.